UK Markets open in 8 hrs

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7500-0.0400 (-1.06%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 36.3500
52-week low 32.3300
50-day moving average 33.2908
200-day moving average 34.0592

Share statistics

Avg vol (3-month) 315.86k
Avg vol (10-day) 310.43k
Shares outstanding 510.22M
Implied shares outstanding 6N/A
Float 87.84M
% held by insiders 123.35%
% held by institutions 13.54%
Shares short (28 Apr 2022) 435.28k
Short ratio (28 Apr 2022) 43.28
Short % of float (28 Apr 2022) 40.45%
Short % of shares outstanding (28 Apr 2022) 40.34%
Shares short (prior month 30 Mar 2022) 4111.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-97.21%
Return on equity (ttm)-168.71%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-12.75M
Diluted EPS (ttm)-1.4790
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.96M
Total cash per share (mrq)1.27
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)15.71
Book value per share (mrq)1.41

Cash flow statement

Operating cash flow (ttm)-5.01M
Levered free cash flow (ttm)-208.37k